SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-000118
Filing Date
2024-01-05
Accepted
2024-01-05 17:26:01
Documents
16
Period of Report
2024-01-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pmn-20240105x8k.htm   iXBRL 8-K 38235
2 EX-1.1 pmn-20240105xex1d1.htm EX-1.1 321354
3 EX-5.1 pmn-20240105xex5d1.htm EX-5.1 12694
4 GRAPHIC pmn-20240105xex5d1001.jpg GRAPHIC 3086
  Complete submission text file 0001558370-24-000118.txt   570791

Data Files

Seq Description Document Type Size
5 EX-101.SCH pmn-20240105.xsd EX-101.SCH 3952
6 EX-101.DEF pmn-20240105_def.xml EX-101.DEF 2872
7 EX-101.LAB pmn-20240105_lab.xml EX-101.LAB 17907
8 EX-101.PRE pmn-20240105_pre.xml EX-101.PRE 11838
10 EXTRACTED XBRL INSTANCE DOCUMENT pmn-20240105x8k_htm.xml XML 4994
Mailing Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2
Business Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 416-847-6898
ProMIS Neurosciences Inc. (Filer) CIK: 0001374339 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41429 | Film No.: 24517585
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)